Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

CROMOLYN SODIUM Drug Profile

« Back to Dashboard

What is the patent landscape for Cromolyn Sodium, and what generic Cromolyn Sodium alternatives are available?

Cromolyn Sodium is a drug marketed by Actavis Mid Atlantic, Bausch And Lomb, Akorn, Mylan Speciality Lp, Apotex Inc, Perrigo, Pharmascience Inc, Micro Labs Ltd India, Wockhardt, Genera Pharms, Watson Labs, Teva Pharms, Roxane, Hh And P, Alcon, and Pack Pharms Llc. and is included in nineteen NDAs.

The generic ingredient in CROMOLYN SODIUM is cromolyn sodium. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.

Summary for Tradename: CROMOLYN SODIUM

Patents:0
Applicants:16
NDAs:19
Suppliers / Packagers: see list11
Bulk Api Vendors: see list53
Clinical Trials: see list926
Patent Applications: see list4,645
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CROMOLYN SODIUM at DailyMed

Pharmacology for Tradename: CROMOLYN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic
CROMOLYN SODIUM
cromolyn sodium
SPRAY, METERED;NASAL074800-001Jul 26, 2001DISCNNoNo► Subscribe► Subscribe
Pack Pharms Llc
CROMOLYN SODIUM
cromolyn sodium
CONCENTRATE;ORAL202583-001Oct 27, 2011AARXNoNo► Subscribe► Subscribe
Apotex Inc
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075333-001Apr 30, 2002DISCNNoNo► Subscribe► Subscribe
Mylan Speciality Lp
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION074209-001Apr 26, 1994ANRXNoNo► Subscribe► Subscribe
Actavis Mid Atlantic
CROMOLYN SODIUM
cromolyn sodium
SOLUTION;INHALATION075067-001Jul 19, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot